Engineers Gate Manager’s Axsome Therapeutics AXSM Stock Holding History

Engineers Gate Manager’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.77M	Sell	16,384 -9,671	-37%	-$1.67M	0.03%	584
2025 Q4	$4.76M	Buy	26,055 +13,877	+114%	+$1.94M	0.06%	360
2025 Q3	$1.48M	Sell	12,178 -4,478	-27%	-$504K	0.02%	944
2025 Q2	$1.74M	Sell	16,656 -7,633	-31%	-$808K	0.02%	801
2025 Q1	$2.83M	Buy	24,289 +17,599	+263%	+$2M	0.05%	558
2024 Q4	$566K	Buy	6,690 +1,493	+29%	+$137K	0.01%	1346
2024 Q3	$467K	Buy	+5,197	New	+$454K	0.01%	1407
2021 Q3	–	Sell	-18,039	Closed	-$1.22M	–	1639
2021 Q2	$1.22M	Buy	18,039 +7,167	+66%	+$430K	0.08%	349
2021 Q1	$616K	Buy	10,872 +2,516	+30%	+$177K	0.03%	861
2020 Q4	$681K	Buy	+8,356	New	+$625K	0.03%	787
2020 Q3	–	Sell	-5,285	Closed	-$435K	–	1666
2020 Q2	$435K	Sell	5,285 -4,299	-45%	-$331K	0.02%	1023
2020 Q1	$564K	Buy	+9,584	New	+$781K	0.04%	697

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Engineers Gate Manager's AXSM Position: Q1 2026 in Review

Engineers Gate Manager reduced its Axsome Therapeutics (AXSM) stake by 37% in Q1 2026, selling an estimated $1.67M and leaving 16,384 shares worth $2.77M. The position accounts for 0.03% of the portfolio, ranked #584.

Engineers Gate Manager first reported a position in AXSM in Q1 2020 and has held it in 12 quarters since. The position peaked at $4.76M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

Engineers Gate Manager held 16,384 shares of Axsome Therapeutics worth $2.77M as of Q1 2026.
Engineers Gate Manager sold 9,671 Axsome Therapeutics shares in Q1 2026, an estimated $1.67M.
Axsome Therapeutics made up 0.03% of Engineers Gate Manager's portfolio in Q1 2026, its #584 holding.
Engineers Gate Manager first reported a position in Axsome Therapeutics in Q1 2020 and has held it in 12 quarters since.
Engineers Gate Manager's Axsome Therapeutics position peaked at $4.76M in Q4 2025.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.